Canadian Neurological Sciences Federation (CNSF) 2021 Congress
Dementia and Cognitive Disorders
Poster Presentations
P.016 Hypertensive disorders in pregnancy are associated with future development of vascular dementia: A systematic review and meta-analysis
-
- Published online by Cambridge University Press:
- 05 January 2022, p. S24
-
- Article
-
- You have access
- Export citation
Epilepsy and EEG
Poster Presentations
P.017 Nutritional deficiency: A mysterious case of psychosis and seizures
-
- Published online by Cambridge University Press:
- 05 January 2022, p. S24
-
- Article
-
- You have access
- Export citation
P.018 The Ottawa Epilepsy Program: region-wide coordinated and multidisciplinary care in the 21st century
-
- Published online by Cambridge University Press:
- 05 January 2022, p. S25
-
- Article
-
- You have access
- Export citation
P.019 A machine learning approach to asymmetric burst suppression and refractory status epilepticus outcome
-
- Published online by Cambridge University Press:
- 05 January 2022, p. S25
-
- Article
-
- You have access
- Export citation
P.020 The North American AED Pregnancy Registry: A Canadian Subgroup Analysis (1997-2019)
-
- Published online by Cambridge University Press:
- 05 January 2022, p. S25
-
- Article
-
- You have access
- Export citation
P.021 Electdetect: An Artificial Neural Network for the Detection of Artifacts in intracranial EEG Recordings From Patients with Epilepsy
-
- Published online by Cambridge University Press:
- 05 January 2022, pp. S25-S26
-
- Article
-
- You have access
- Export citation
P.022 The effect of vagus nerve stimulation on the quality of sleep in medically refractory epileptic patients
-
- Published online by Cambridge University Press:
- 05 January 2022, p. S26
-
- Article
-
- You have access
- Export citation
P.023 Neurostimulation in Drug-Resistant Epilepsy: Systematic Review and Meta-Analysis from the ILAE Evidence-Based Epilepsy Surgery Task Force
-
- Published online by Cambridge University Press:
- 05 January 2022, p. S26
-
- Article
-
- You have access
- Export citation
Genetic/Metabolic Disease
Poster Presentations
P.024 A multi-faceted lifestyle intervention for mitochondrial A8344G associated multiple symmetric lipomatosis (MSL): a successful patient initiated novel therapy
-
- Published online by Cambridge University Press:
- 05 January 2022, p. S26
-
- Article
-
- You have access
- Export citation
P.025 Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in participants with late-onset Pompe disease (LOPD)
-
- Published online by Cambridge University Press:
- 05 January 2022, p. S27
-
- Article
-
- You have access
- Export citation
Headache
Poster Presentations
P.026 Erenumab associated with high persistence among Canadian patients for preventive treatment of chronic and episodic migraine in real-world practice
-
- Published online by Cambridge University Press:
- 05 January 2022, p. S27
-
- Article
-
- You have access
- Export citation
P.027 Efficacy and Safety of Eptinezumab Initiated During a Migraine Attack: Results from the RELIEF Study
-
- Published online by Cambridge University Press:
- 05 January 2022, pp. S27-S28
-
- Article
-
- You have access
- Export citation
P.028 Surgical Treatment for Idiopathic Intracranial Hypertension – Strategy for the Better Management
-
- Published online by Cambridge University Press:
- 05 January 2022, p. S28
-
- Article
-
- You have access
- Export citation
P.029 Oral Daily Atogepant for the Preventive Treatment of Migraine Increases Responder Rates for Reduction in Mean Monthly Migraine Days
-
- Published online by Cambridge University Press:
- 05 January 2022, p. S28
-
- Article
-
- You have access
- Export citation
P.030 Long-term Safety and Tolerability of Atogepant 60 mg Following Once-Daily Dosing Over 1 Year for the Preventive Treatment of Migraine
-
- Published online by Cambridge University Press:
- 05 January 2022, pp. S28-S29
-
- Article
-
- You have access
- Export citation
P.031 A Rare Canadian Case of Cervical Pyomyosistis Presenting as Occipital Neuralgia
-
- Published online by Cambridge University Press:
- 05 January 2022, p. S29
-
- Article
-
- You have access
- Export citation
P.032 Long-term safety and tolerability of eptinezumab in patients with chronic migraine: A 2-year, open-label, phase 3 trial
-
- Published online by Cambridge University Press:
- 05 January 2022, p. S29
-
- Article
-
- You have access
- Export citation
P.033 Eptinezumab reduced acute medication use in patients with chronic migraine and medication-overuse headache: subgroup analysis of Promise-2
-
- Published online by Cambridge University Press:
- 05 January 2022, p. S29
-
- Article
-
- You have access
- Export citation
P.034 Eptinezumab Demonstrated Early Relief from Episodic and Chronic Migraine: Consistency of Effect Across 4 Clinical Trials
-
- Published online by Cambridge University Press:
- 05 January 2022, p. S30
-
- Article
-
- You have access
- Export citation
P.035 Health System Utilization and Medication Use among Adults with Migraine in Alberta: An observational cohort study using Alberta administrative health data
-
- Published online by Cambridge University Press:
- 05 January 2022, p. S30
-
- Article
-
- You have access
- Export citation